InvestorsHub Logo
Followers 65
Posts 23947
Boards Moderated 0
Alias Born 11/23/2016

Re: hebbeke47 post# 120696

Tuesday, 09/19/2017 4:29:34 AM

Tuesday, September 19, 2017 4:29:34 AM

Post# of 462961
https://endpts.com/cut-loose-from-biogen-buyout-option-rodin-preps-for-an-early-stage-shot-at-alzheimers/

Biogen remains an investor in the company, says Rosenberg, but dropped its buyout option after a “mutual agreement” driven by shifting priorities.



Rodin's or Biogen's priorities? A stretch to imagine, but could Biogen be more interested in Anavex...guess that is your inference?

Rodin's operating model seems very similar to the way Missling is running a small Biotech.

Hope Falconer or others can enlighten us on "HDAC inhibitor".

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News